Skip to main content

Find Clinical Trials

Home
Conditions
HER2-positive Breast Cancer

Clinical trial condition

HER2-positive Breast Cancer

Explore clinical trials studying HER2-positive Breast Cancer. Study availability and eligibility vary by location and protocol.

202 public trials 83 recruiting studies

Refine in advanced search Browse all conditions

HER2-positive Breast Cancer trial results

Not Yet Recruiting

T-DXd Versus THP for Medium-risk HER2-positive Early Breast Cancer

NCT06548178

Conditions: HER2-positive Breast Cancer
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

Thero2-01S22 in HER2-positive Breast Cancer

NCT05698186

Conditions: HER2-positive Breast Cancer
Locations: Not specified

View Trial Details

Not Yet Recruiting

Protocol for Herceptin as Adjuvant Therapy With Reduced Exposure to Chemotherapy (PHARE-C)

NCT05388500

Conditions: HER2-positive Breast Cancer
Locations: Not specified

View Trial Details

Not Yet Recruiting

Avoiding Sentinel Lymph Node Biopsy in Breast Cancer Patients After Neoadjuvant Chemotherapy

NCT04225858

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Adjuvant Dual Anti-HER2 Therapy in Patients With Small, Node-negative, HER2-positive Breast Cancer

NCT04158856

Conditions: HER2-positive Breast Cancer
Locations: Not specified

View Trial Details

Completed

HER-TEMPO - Real World Treatment-related Outcomes on T-DXd in Canada

NCT06386263

Conditions: Breast Diseases, Breast Neoplasms, HER2-low Expressing Breast Cancer, +7 more
Locations: Research Site Oakville, Ontario, Canada

View Trial Details

Completed

Real World Patient-Reported Outcomes in Chinese Her2+ EBC Patients Receiving (Neo) Adjuvant Anti-Her2 Based Therapy

NCT06161922

Conditions: HER2-positive Breast Cancer
Locations: Keda Yu Shanghai, China

View Trial Details

Completed

TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer

NCT03179904

Conditions: Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, +2 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Completed

99mTc-DARPinG3-based HER2 Expression Molecular Imaging in HER2-positive Breast Cancer During Chemo+Targeted Therapy

NCT05412459

Conditions: Breast Diseases, Breast Neoplasms, Female, +5 more
Locations: Tomsk NRMC Tomsk, Russia

TomskNRMC Tomsk, Russia

View Trial Details

Completed

Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer

NCT01730833

Conditions: Breast Adenocarcinoma, Breast Diseases, Breast Neoplasms, +14 more
Locations: City of Hope Medical Center Duarte, California, United States

City of Hope Antelope Valley Lancaster, California, United States

City of Hope- South Pasadena Cancer Center South Pasadena, California, United States

View Trial Details